Fundraising Fox

Fidelis Pharmaceuticals

North Brunswick, US · Delaware corporation

Biotech

Founders & leadership

BL
Barry LevinsonNamed on SEC filing
DS
Dennis SteadmanNamed on SEC filing
CD
Cynthia DavisNamed on SEC filing
SW
Susan WithamNamed on SEC filing
SL
Steven LearyNamed on SEC filing
AM
Andrew MidlerNamed on SEC filing
KS
Kenneth SylvesterNamed on SEC filing
ES
Eric SchreiberNamed on SEC filing
MW
Michael WellsNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$6.1M disclosed across 2 rounds · 2021–2024

▶$1MraisedFeb 2024 · 10 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Andrew MidlerDirector
  • Michael WellsExecutive Officer, Director, Promoter
  • Susan WithamExecutive Officer
  • Dennis SteadmanDirector
  • Steven LearyExecutive Officer
  • Barry LevinsonExecutive Officer, Director, Promoter
  • Cynthia DavisExecutive Officer
Offering amount
$2M
Amount sold
$1M
First sale
Feb 2024
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.1MraisedJul 2021 · 8 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Barry LevinsonExecutive Officer, Director, Promoter
  • Dennis SteadmanDirector
  • Cynthia DavisExecutive Officer
  • Susan WithamExecutive Officer
  • Steven LearyExecutive Officer
  • Andrew MidlerDirector
  • Kenneth SylvesterExecutive Officer
  • Eric SchreiberExecutive Officer
  • Michael WellsExecutive Officer, Director, Promoter
Offering amount
$5.1M
Amount sold
$5.1M
First sale
Apr 2021
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

How much funding has Fidelis Pharmaceuticals raised?
Fidelis Pharmaceuticals has disclosed $6.1M raised across 2 rounds.
Where is Fidelis Pharmaceuticals headquartered?
Fidelis Pharmaceuticals is headquartered in North Brunswick, US.